BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Rebellious FDA Reviewer Insists ARB Heart Drugs Have Cancer Risk


5/31/2013 8:45:41 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Yet another instance of an FDA medical reviewer clashing with agency supervisors is playing out over a group of drugs called angiotension receptor blockers, which are taken by millions of people to prevent heart attacks and strokes, but were linked to a higher risk of cancer in a 2010 study in The Lancet. Although the agency later determined there was no increased risk and cleared the drugs for continued use the following year, FDA reviewer Tom Marciniak disagreed with the agency analysis and maintains stronger warnings are needed, according to The Wall Street Journal. To reach its conclusion, the agency conducted a meta-analysis of existing studies, but Marciniak, a cancer expert, believes some of those studies had flaws that tainted the ultimate outcome, the paper reports. One example: the analysis did not count tally cases of lung carcinomas as lung cancer.

Help employers find you! Check out all the jobs and post your resume.


Read at PharmaLive
Read at Wall Street Journal
Read at Forbes

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES